Table 5

Spearman rank correlation results for six laboratory-based risk scores, each compared to non-laboratory-based risk score, women
Dataset Number Fr_CVD_08[11] Fr_CVD_91 [10] Fr_CHD_91 [10] SCORE_h[4]a SCORE_l [4]a CUORE[12]
Aggregate 9,021 0.933 0.937 0.925 0.984 0.985 0.969
BRISK 357 0.938 0.949 0.968 0.992 0.992 0.964
CRIBSA 646 0.944 0.948 0.950 0.987 0.987 0.977
Mangaung 442 0.945 0.943 0.935 0.989 0.989 0.974
QwaQwa 535 0.943 0.951 0.933 0.991 0.992 0.981
AHA-FS Urban 295 0.918 0.912 0.904 0.978 0.978 0.964
AHA-FS Rural 361 0.910 0.903 0.884 0.967 0.969 0.956
PURE, Urban 539 0.904 0.889 0.830 0.977 0.979 0.949
PURE, Rural 607 0.888 0.884 0.844 0.975 0.977 0.930
KwaZulu-Natal 612 0.944 0.958 0.936 0.991 0.992 0.981
CRISIC 393 0.950 0.944 0.950 0.990 0.990 0.961
Mamre 399 0.949 0.944 0.953 0.989 0.989 0.952
KORIS 3,037 0.950 0.951 0.937 0.991 0.991 0.974
Phoenix 798 0.909 0.901 0.895 0.964 0.965 0.966

aFramingham 10-year CVD risk of >20% of fatal and non-fatal events is equivalent to 5% risk of fatal events for SCORE. CHD coronary heart disease, CVD cardiovascular disease, Fr Framingham.

Gaziano et al.

Gaziano et al. BMC Medicine 2013 11:170   doi:10.1186/1741-7015-11-170

Open Data